FTXH Holdings Information

FTXH is an equity ETF with a total of 51 individual holdings. The top holdings are Eli Lilly and Company stock at 7.57%, Merck & Co. at 7.39%, Bristol-Myers Squibb Company at 7.13%, Johnson & Johnson at 7.05%, and AbbVie at 6.95%.

Total Holdings

Top 10 Percentage

54.16%

Asset Class

Equity

ETF Category

Health

Assets

34.86M

PE Ratio

19.45

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	7.57%	2,475
2	MRK	Merck & Co., Inc.	7.39%	21,021
3	BMY	Bristol-Myers Squibb Company	7.13%	41,733
4	JNJ	Johnson & Johnson	7.05%	10,477
5	ABBV	AbbVie Inc.	6.95%	11,216
6	VTRS	Viatris Inc.	4.17%	87,169
7	BIIB	Biogen Inc.	3.77%	6,784
8	PFE	Pfizer Inc.	3.50%	47,068
9	GILD	Gilead Sciences, Inc.	3.37%	8,738
10	CAH	Cardinal Health, Inc.	3.27%	5,678
11	VRTX	Vertex Pharmaceuticals Incorporated	3.27%	2,620
12	AMGN	Amgen Inc.	3.27%	3,353
13	UTHR	United Therapeutics Corporation	3.13%	1,920
14	REGN	Regeneron Pharmaceuticals, Inc.	3.05%	1,665
15	JAZZ	Jazz Pharmaceuticals plc	2.72%	3,943
16	ZTS	Zoetis Inc.	2.32%	9,927
17	INCY	Incyte Corporation	2.25%	8,062
18	ILMN	Illumina, Inc.	1.79%	4,308
19	EXEL	Exelixis, Inc.	1.74%	12,111
20	NBIX	Neurocrine Biosciences, Inc.	1.39%	3,099
21	PTCT	PTC Therapeutics, Inc.	1.27%	6,420
22	MEDP	Medpace Holdings, Inc.	1.27%	1,019
23	HALO	Halozyme Therapeutics, Inc.	1.16%	5,896
24	BMRN	BioMarin Pharmaceutical Inc.	1.16%	7,443
25	CRL	Charles River Laboratories International, Inc.	1.15%	2,505

Showing 25 of 51 holdings

Subscribe to see the full list

Activate Now

As of May 25, 2026